| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |